Get the Stockscreener App
1.85
3.65%
-0.07
After Hours:
1.82
-0.03
-1.62%
Compugen Ltd stock is traded at $1.85, with a volume of 865.80K.
It is down -3.65% in the last 24 hours and up +32.14% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
See More
Previous Close:
$1.92
Open:
$1.95
24h Volume:
865.80K
Relative Volume:
3.00
Market Cap:
$179.59M
Revenue:
-
Net Income/Loss:
$1.60M
P/E Ratio:
61.67
EPS:
0.03
Net Cash Flow:
$-62.91M
1W Performance:
+13.50%
1M Performance:
+32.14%
6M Performance:
+52.89%
1Y Performance:
+7.56%
1-Day Range:
$1.85
$1.99
1-Week Range:
$1.65
$1.99
52-Week Range:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.85 | 179.59M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
What drives Compugen Ltd stock priceMarket Sentiment Shifts & Investment Risk Management Tips - earlytimes.in
How to use a screener to detect Compugen Ltd. breakoutsMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
Does Compugen Ltd. fit your quant trading modelJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com
Compugen (NASDAQ:CGEN) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Compugen Ltd. (NASDAQ:CGEN) Held Back By Insufficient Growth Even After Shares Climb 34% - 富途牛牛
Signal strength of Compugen Ltd. stock in tech scannersTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Compugen's (CGEN) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Building trade automation scripts for Compugen Ltd.2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
Detecting support and resistance levels for Compugen Ltd.July 2025 PostEarnings & Community Verified Trade Signals - newser.com
How Compugen Ltd. stock performs in stagflationGDP Growth & Weekly Top Gainers Trade List - newser.com
There's No Escaping Compugen Ltd.'s (NASDAQ:CGEN) Muted Revenues Despite A 25% Share Price Rise - simplywall.st
First-in-Human COM503 Trial — Compugen to Present Poster at SITC Nov 7, 2025 in National Harbor - Stock Titan
Can Compugen Ltd. stock double in next 5 yearsEarnings Overview Summary & AI Forecast Swing Trade Picks - newser.com
Relative strength of Compugen Ltd. in sector analysisJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Regression analysis insights on Compugen Ltd. performanceTrade Entry Summary & High Yield Equity Trading Tips - newser.com
Can momentum traders help lift Compugen Ltd.Weekly Market Outlook & AI Powered Trade Plan Recommendations - newser.com
Using economic indicators to assess Compugen Ltd. potentialAnalyst Upgrade & Risk Controlled Daily Trade Plans - newser.com
Backtesting results for Compugen Ltd. trading strategies2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
Automated trading signals detected on Compugen Ltd.July 2025 PostEarnings & Verified Chart Pattern Signals - newser.com
What is the fair value of Compugen Ltd. stock nowWeekly Stock Report & Smart Swing Trading Techniques - newser.com
Published on: 2025-10-03 02:11:14 - newser.com
Here's Why We're Not At All Concerned With Compugen's (NASDAQ:CGEN) Cash Burn Situation - simplywall.st
Goldman Sachs Group Inc. Has $85,000 Stake in Compugen Ltd. $CGEN - Defense World
Published on: 2025-09-30 04:57:22 - newser.com
What analysts say about Compugen Ltd stockMid Cap Growth Trends & Build Wealth Brick by Brick With Us - earlytimes.in
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):